Although I feel the company is worth more, today I will sell the remaining shares I own of Valeant (VRX) as this sad story will take a while to unfold.
Valeant Pharmaceuticals (VRX) continues to surge ahead, with profit growth expected to surpass 50% later this year. VRX stock is a bargain at 22x earnings and is one of my top holdings.